Delhi Air Turns ‘Severe’: Schools Go Hybrid, Work-From-Home UrgedDelhi’s air quality has plummeted to the ‘severe’ category once again, triggering Stage-IV restrictions under the Graded Response Action Plan (GRAP). The Commission for Air Quality Management (CAQM) announced emergency curbs to combat the alarming pollution spike, driven by stagnant weather, low wind speed, and dense fog.
on
December 17, 2024
India’s First Diabetes Biobank Unveiled in Chennai for Advanced ResearchIndia’s first diabetes biobank, a pioneering initiative by the Indian Council of Medical Research (ICMR) in collaboration with the Madras Diabetes Research Foundation (MDRF), has been launched in Chennai. This state-of-the-art repository aims to revolutionize diabetes research by storing, processing, and distributing biological samples to support advanced studies on diabetes and its complications.
on
December 16, 2024
Yoga as a Game-Changer in Diabetes Prevention: RSSDI Study Highlights 40% Risk ReductionA groundbreaking study released by Union Minister Dr. Jitendra Singh has revealed that a daily 40-minute yoga routine, incorporating select asanas and pranayama, can reduce the risk of developing Type-2 diabetes by approximately 40% in prediabetic individuals. The study, titled “Yoga and Prevention of Type 2 Diabetes – The Indian Prevention of Diabetes Study”, was conducted by the Research Society for the Study of Diabetes in India (RSSDI) and published in the esteemed journal Diabetes and Metabolic Syndrome: Clinical Research and Reviews.
on
December 14, 2024
Revolutionary Gene Therapy for Hemophilia A Developed in IndiaIn a landmark achievement, Indian scientists have successfully trialed a novel gene therapy for severe Hemophilia A, potentially eliminating the need for frequent and costly clotting factor injections. The trial, conducted by Dr. Alok Srivastava and his team at the Centre for Stem Cell Research (CSCR), Christian Medical College, Vellore, involved five patients who reported no bleeding episodes over 14 months. The study was recently published in the prestigious New England Journal of Medicine (NEJM).
on
December 13, 2024
Cipla Brings Inhaled Insulin to IndiaCipla Limited, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to distribute and market Afrezza®, a groundbreaking inhaled insulin, in India. This innovation, developed by MannKind Corporation (USA), marks a significant step in diabetes care, providing a needle-free alternative for managing both type 1 and type 2 diabetes mellitus.
on
December 12, 2024

Featured

FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#

newfeature

#

Partnership

#

funding